Drugs Flashcards
(22 cards)
Propofol (diprovan) use and MOA
anti-microbial and anti-emetic properties
hypnotic
dissociates GABA from receptor
Propofol (diprovan) - metabolism, elimination
liver, kidney
Propofol (diprovan) considerations
venous dilation, bronchodilation,
decrease BP (preload, afterload, contractility)
respiratory depression, neuroprotective (decreases CBF, ICP)
lidocaine 2% use/dose
propofol causes pain peripherally
0.5-1 mg/kg IV prior to propofol administration
Propofol (diprovan) - dose
1-2.5 mg/kg IV - induction
100-200 mcg/kg/min - TIVA
25-75 mcg/kg/min - conscious sedation
10 mcg/kg/min - antiemetic
2-4 min half-life
PRIS (propofol infusion syndrome)
usually from long term, high dose therapy: hypotension, dysrhythmias, rhabdo, ARF, hepatomegaly, metabolic acidosis, hyperkalemia, lipedemia
barbiturates - MOA
bind to GABAa receptors, depress RAS, suppress acetylcholine transmission
barbiturates
anticonvulsant, decreased vasc resistance, muscle excitation, myocardial and respiratory depression, decreased CRMO2, sedation, hypnosis
barbiturates contraindication
porphyria, heme synthesis metabolic error::: Severe abdominal pain, N/V, ANS instability, electrolyte disturbances, muscle weakness, neuropsychiatric changes including seizures, cardiac instability
thiopenthal
usually 500mg vial, dilute with 20 ml sterile water - 25mg/ml
adult dosing 3-5mg/kg
peak at 1 min, 5-8 min duration of action
methohexitol (brevitol)
1-2 mg/kg IV
ultra-short acting barbiturate
etomidate (amidate)
20mg/10ml = 2 mg/ml GABA mimetic Known for its CV stability!! Reduces CBF, ICP, CMR02 anticonvulsant ADRENAL SUPRESSION 0.2-0.4 mg/kg
benzodiazepines - effect
Anxiolysis Amnesia Sedation Muscle relaxation Hypnosis Anticonvulsant
benzodiazepines - commonly used
Midazolam (Versed) Half-life (1.7-2.6 hrs) Lorazepam (Ativan) Half-life (10-22 hrs) Diazepam (Valium) Half-life (36-50 hrs)
Flumazenil (Romazicon)
Benzodiazepine antagonist
Initial dose: 0.2 mg IV ; repeat doses at 0.1 mg IV (max total 1 mg IV)
Duration of action 30-60 minutes
Continuous infusion: 0.1 – 0.4 mg/hr IV
midazolam (versed) dosing
0.1-0.2 mg/kg IV
0.5 - 2 mg preoperative (adult)
Peds 0.05 - 0.1 mg/kg IV/IM
Oral: 0.05 – 1 mg/kg (30 min prior)
Rectal / Intranasal: 0.2 – 0.3 mg/kg
ketamine - concentration and dosing
200mg/20ml = 10 mg/ml
Induction: 2-4 mg/kg IV; 4-6 mg/kg IM
Sedation/analgesia: 0.2-0.8 mg/kg IV (over 2-3 min) followed by infusion (5-120 mcg/kg/min)
10-20 mg (pre-emptive analgesia)
ketamine - receptor and action
NMDA receptor (inhibits glutamate)
Moderate analgesic
Unconsciousness, amnesia
ketamine cautions
in patients with: HTN, angina, CHF, increased ICP, increased IOP, psychiatric disorders, airway issues
increases muscle tone, post op N&V, cardiac stimulant (increases everything), salivation (treat with glycopyrolate), increases CBF
good patients for ketamine
Shock or cardiovascular instability Severe dehydration Bronchospasm Severe anemia Burn dressing changes OB – acute hemorrhage Poor risk patients (trauma /elderly)
dexmeditomidine (precedex)
Selective alpha-2 adrenoreceptor agonist
dexmeditomidine dosing
Requires infusion pump (syringe pump)
Start bolus of1 mcg/kg over 10 minutes
Start maintenance infusion 0.6 mcg/kg/hour